Provider review, September 2026
Näky prints its headline growth-hormone figure and its month-to-month figure inside one sentence, in brackets, and then publishes the prepaid total that the headline divides into — so a reader can check the arithmetic without leaving the page.
Näky is not a paid partner; this link may earn a commission if that changes. Full disclosure.
The product title line reads: the product name, the dosing frequency, a starting-at figure, and then in brackets a higher figure described as the month-to-month rate.
That construction is unusual and it is good. The two numbers cannot be separated by a reader skimming, by a screenshot, or by a comparison table pulling the first figure it finds, because they are in the same string.
Lower on the page the seller publishes both plan options with their totals: a one-month supply at the higher figure and a three-month supply at a total that divides to the headline exactly.
So the headline is a prepayment divided by three, and the seller has published everything needed to establish that. This roster records the month-to-month figure and shows the arithmetic in the qualifier.
The page states there are no hidden fees and no surprise charges. Sellers on this roster make that claim routinely and it is usually unfalsifiable from the page.
Here it is at least consistent with what the page shows: two plan options, both totals published, no membership line, no separate consultation charge and no asterisk resolving elsewhere.
That is not proof, and this review does not present it as one. It is a claim made on a page that does not contradict it, which distinguishes it from several sellers in this batch whose pages do.
The coenzyme this seller also carries had no figure on the pages read, so only one compound is priced here.
An earlier sweep of this market recorded this host returning a rate-limiting response on two consecutive passes. A third pass, one request at a time with several seconds between fetches, returned normally.
The same pattern held across nine hosts in that sweep, all of them alive, all of them returning the same response body size — which made a probing artefact look like a consistent signal about nine unrelated companies.
This seller is on the roster because that was re-tested rather than accepted. A rate limit describes the probe; it never describes the business.
It does have one consequence for readers: a person checking several pages on this site quickly may be blocked as well.
The terms name the operating company in capitals and in title case, name the clinical practice separately, and name the platform vendor whose terms the seller incorporates by reference.
All three are real disclosures. Two of them stand behind several other brands on this roster, so they describe the sector's structure rather than distinguishing this seller within it.
One of the named clinical entities appears behind another seller in this batch in a different corporate form, which is worth noting for anyone trying to map who actually delivers care in this market.
Screened by the operating company, the clinical practice, the platform vendor and the brand against the regulator's warning-letter index, no letter names this seller. No dispensing pharmacy is named, no certificate of analysis exists on the pages read, and no state coverage list is published.
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.
Auren Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Auren RxThe seller prints it in brackets in the same sentence as the headline figure, and it is higher. The headline is a three-month prepayment divided by three.
Yes. Both plan options are published with their totals, and the three-month total divides exactly to the headline figure.
No figure for it was found on the pages read.
Its host returned a rate-limiting response to concurrent probes on two earlier passes. One request at a time it responded normally.
The terms name a professional corporation separately from the brand, and name the platform vendor whose terms are incorporated by reference.
Näky is not a paid partner; this link may earn a commission if that changes. Full disclosure.